These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3094571)

  • 1. The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration.
    Neale MG; Brown K; Hodder RW; Auty RM
    Br J Clin Pharmacol; 1986 Oct; 22(4):373-82. PubMed ID: 3094571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic assessment of sodium cromoglycate.
    Fuller RW; Collier JG
    J Pharm Pharmacol; 1983 May; 35(5):289-92. PubMed ID: 6134796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique.
    Richards R; Dickson CR; Renwick AG; Lewis RA; Holgate ST
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1028-32. PubMed ID: 3110405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep inspiration increases the absorption of inhaled sodium cromoglycate.
    Richards R; Fowler C; Simpson SF; Renwick AG; Holgate ST
    Br J Clin Pharmacol; 1989 Jun; 27(6):861-5. PubMed ID: 2503020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.
    Taylor KM; Taylor G; Kellaway IW; Stevens J
    Pharm Res; 1989 Jul; 6(7):633-6. PubMed ID: 2508078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler.
    Auty RM; Brown K; Neale MG; Snashall PD
    Br J Dis Chest; 1987 Oct; 81(4):371-80. PubMed ID: 3130088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.
    Richards R; Fowler C; Simpson S; Renwick AG; Holgate ST
    Br J Clin Pharmacol; 1992 Mar; 33(3):337-41. PubMed ID: 1576060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intravenous sodium cromoglycate on the bronchoconstriction induced by sulphur dioxide inhalation in man.
    Allistone A; Collier JG; Davidson RN; Fuller RW; Richardson PS
    Clin Sci (Lond); 1985 Feb; 68(2):227-32. PubMed ID: 3917884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nasal absorption of sodium cromoglycate in the albino rat.
    Fisher AN; Brown K; Davis SS; Parr GD; Smith DA
    J Pharm Pharmacol; 1985 Jan; 37(1):38-41. PubMed ID: 2858525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium cromoglycate in asthma: correlation between response and serum concentrations.
    Yahav Y; Dany S; Katznelson D; Farfel Z
    Arch Dis Child; 1988 Jun; 63(6):592-7. PubMed ID: 3133990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methacholine induced bronchoconstriction on the pulmonary distribution and plasma pharmacokinetics of inhaled sodium cromoglycate in subjects with normal and hyperreactive airways.
    Richards R; Haas A; Simpson S; Britten A; Renwick A; Holgate S
    Thorax; 1988 Aug; 43(8):611-6. PubMed ID: 3140407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma.
    Richards R; Simpson SF; Renwick AG; Holgate ST
    Eur Respir J; 1988 Dec; 1(10):896-901. PubMed ID: 3147196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative lung bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device.
    Aswania O; Chrystyn H
    Pulm Pharmacol Ther; 2001; 14(2):129-33. PubMed ID: 11273794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an ion-pair liquid chromatographic method for the quantitation of sodium cromoglycate in urine following inhalation.
    Aswania OA; Corlett SA; Chrystyn H
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):373-8. PubMed ID: 9106069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple pharmacokinetic method to evaluate the pulmonary dose in clinical practice--analyses of inhaled sodium cromoglycate.
    Lindström M; Svensson JO; Meurling L; Svartengren K; Anderson M; Svartengren M
    Respir Med; 2004 Jan; 98(1):9-16. PubMed ID: 14959808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation.
    Aswania O; Chrystyn H
    Biopharm Drug Dispos; 2002 May; 23(4):159-63. PubMed ID: 12015790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of ( 14 C)disodium cromoglycate in man.
    Walker SR; Evans ME; Richards AJ; Paterson JW
    J Pharm Pharmacol; 1972 Jul; 24(7):525-31. PubMed ID: 4403844
    [No Abstract]   [Full Text] [Related]  

  • 18. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption, excretion and metabolism of disodium (14C)cromoglycate in man.
    Walker SR; Richards AJ; Paterson JW
    Biochem J; 1971 Nov; 125(2):27P. PubMed ID: 5004195
    [No Abstract]   [Full Text] [Related]  

  • 20. [HPLC-MS/MS method for determination of sodium cromoglycate concentration in human plasma and its pharmacokinetics].
    Xu XY; Zhang R; Yuan GY; Wang BJ; Liu XY; Guo RC
    Yao Xue Xue Bao; 2008 Sep; 43(9):942-5. PubMed ID: 19048787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.